Diagnosis, prevention and risk-management of drug-induced liver injury due to medications used to treat mycobacterium tuberculosis-Reference-Cited by-同舟云学术

Diagnosis, prevention and risk-management of drug-induced liver injury due to medications used to treat mycobacterium tuberculosis

Published:2024-09-04 Issue: Volume: Page:1-15
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Lewis James H.¹,Korkmaz Serena Y.²^ORCID,Rizk Courtney A.²,Copeland Matthew J.³

Affiliation:

1. Department of Medicine, Division of Gastroenterology-Hepatology, Medstar Georgetown University Hospital, Washington, DC, USA

2. Department of Medicine, General Internal Medicine, Medstar Georgetown University Hospital, Washington, DC, USA

3. Department of Medicine, Division of Infectious Diseases, Washington, DC, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2024.2399074

Reference130 articles.

1. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling

2. WHO. Global TB global tuberculosis report 2023. Geneva: world health organization © world health organization 2023. 2023 [cited 2024 Jul 1st]. Available from: https://iris.who.int/bitstream/handle/10665/373828/9789240083851-eng.pdf?sequence=1

3. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020

4. Tuberculosis (TB) in the United States by the numbers2024. [cited 2024 Jul 1st]. Available from: https://www.cdc.gov/tb/statistics/default.htm

5. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis